Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.02 |